Search Ontology:
ChEBI

alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpN

Term ID
CHEBI:148785
Synonyms
  • (2S,3S,4R,5S,6S)-2-[(2R,3R,4S,5R,6R)-2-[(2R,3R,4R,5S,6R)-3-amino-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol
  • 6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-beta-D-galacto-hexopyranosyl-(1->3)-2-amino-2-deoxy-beta-D-gluco-hexopyranose
  • 6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-amino-2-deoxy-beta-D-glucopyranose
  • alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->3)-2-amino-2-deoxy-beta-D-glucopyranose
  • Fuc(a1-2)Gal(b1-3)b-GlcN
Definition
An amino trisaccharide consisting of α-L-fucopyranose, β-D-galactopyranose and 2-amino-2-deoxypyranose joined in sequence by (1→2) and (1→3) glycosidic bonds.
References
  • glygen:G23935WM
  • glytoucan:G23935WM
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpN
Phenotype where environments contain alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpN
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpN
Phenotype affecting alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpN
Human Disease Model